SEC EDGAR Filing Information

Form 10-Q -- Quarterly report [Sections 13 or 15(d)]

Period of Report: 2008-06-30
Filing Date Changed: 2008-08-14
Documents: 5

SEC Accession No.
0000812796-08-000030
Filing date: 2008-08-14
Accepted: 2008-08-14 16:50:55

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-Q	dor10q2q2008.htm	615903	DOR 10 Q FOR THE 2ND Q 2008
2	EX-31.1	certceo.htm	13170	DOR CEO CERT
3	EX-31.2	cfocert.htm	12934	DOR CFO CERT
4	EX-32.1	ceo906cert.htm	7365	DOR CEO 906 CERT
5	EX-32.2	cfo906cert.htm	7209	DOR CFO 906 CERT

		0000812796-08-000030.txt	658192	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 081020002
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628